Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 15 years, with Q2 2025 value amounting to $171000.0.

  • Lifecore Biomedical, Inc. \De\'s Other Non Operating Income rose 11551.72% to $171000.0 in Q2 2025 from the same period last year, while for May 2025 it was -$3000.0, marking a year-over-year increase of 9990.17%. This contributed to the annual value of -$3000.0 for FY2025, which is 9990.17% up from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical, Inc. \De\'s Other Non Operating Income is $171000.0, which was up 11551.72% from $333000.0 recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s 5-year Other Non Operating Income high stood at $333000.0 for Q1 2025, and its period low was -$23.4 million during Q2 2023.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Other Non Operating Income value was -$109500.0 (recorded in 2021), while the average stood at -$1.4 million.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Other Non Operating Income soared by 35522.39% in 2021, and later tumbled by 1993983.05% in 2023.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Other Non Operating Income (Quarter) stood at $330000.0 in 2021, then tumbled by 171.82% to -$237000.0 in 2022, then tumbled by 308.02% to -$967000.0 in 2023, then surged by 68.56% to -$304000.0 in 2024, then surged by 156.25% to $171000.0 in 2025.
  • Its Other Non Operating Income was $171000.0 in Q2 2025, compared to $333000.0 in Q1 2025 and -$304000.0 in Q4 2024.